Skip to main content
. 2019 Aug 16;75(3):596–602. doi: 10.1093/gerona/glz182

Table 1.

Participant Characteristics by Presenting Vision Impairment Status: National Health and Nutrition Examination Survey (NHANES)

Overall
n = 2,639
No visual impairmenta
n = 2,315 (91%)
Visual impairment
n = 324 (9%)
p-value
Age, mean ± SD 70.1 ± 7.2 69.6 ± 6.9 75.1 ± 9.0 <.001
Female, n (%) 1,320 (55.6) 1,161 (55.7) 159 (55.6) .975
Race, n (%) <.001
 Non-Hispanic White 1,537 (82.6) 1,374 (84.0) 163 (69.6)
 Non-Hispanic Black 437 (7.5) 380 (7.2) 57 (10.6)
 Mexican American 512 (2.7) 442 (2.6) 70 (3.9)
 Other Hispanics and other race 153 (7.2) 119 (6.3) 34 (16.2)
Body mass index, n (%) (kg/m2) .023
 Underweight (<18.5) 39 (1.6) 32 (1.5) 7 (2.7)
 Normal (18.5–24.9) 698 (27.5) 589 (27.0) 109 (32.8)
 Overweight (25–29.9) 1,018 (37.4) 892 (37.1) 126 (40.6)
 Obese (≥30) 838 (33.5) 764 (34.4) 74 (23.9)
Education, n (%) <.001
 Less than high school 1,085 (29.9) 908 (28.3) 177 (45.2)
 High school or equivalent 629 (29.6) 556 (29.7) 73 (28.5)
 More than high school 920 (40.5) 847 (42.0) 73 (26.3)
Current or former smokers, n (%) 1,391 (53.2) 1,234 (53.7) 157 (48.1) .173
Diabetes, n (%) 452 (14.8) 378 (14.3) 74 (19.1) .071
Total comorbiditiesb, n (%) .059
 0 comorbidities 537 (20.0) 478 (20.5) 59 (15.3)
 1–2 comorbidities 1,602 (60.2) 1,408 (60.3) 194 (59.1)
 >2 comorbidities 500 (19.8) 429 (19.2) 71 (25.6)

Results reported as unweighted n (weighted %). Unadjusted p-values. Bold values denote statistical significance at p < .05 level.

aNo visual impairment defined as presenting visual acuity ≥20/40 in better-seeing eye. Visual impairment defined as presenting visual acuity <20/40 in better-seeing eye.

bTotal comorbidities: angina, arthritis, cancer, congestive heart failure, coronary heart disease, hypertension, liver disease, myocardial infarct, and stroke.